IMPACT Study: A Study of Valcyte (Valganciclovir) for Prevention of Cytomegalovirus Disease (CMV) in Kidney Allograft Recipients
Clinical trial NCT00294515 · COMPLETED
Trial details
- NCT number
- NCT00294515
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2006-03-31
- Primary completion
- 2008-08-31
- Enrollment
- 326
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.